Cargando…
Congenital hypothyroidism after newborn screening program reorganization in the Apulia region
BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a s...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335966/ https://www.ncbi.nlm.nih.gov/pubmed/35906638 http://dx.doi.org/10.1186/s13052-022-01328-0 |
_version_ | 1784759446662021120 |
---|---|
author | Simonetti, Simonetta D’Amato, Gabriele Esposito, Benedetta Chiarito, Mariangela Dentico, Domenico Lorè, Tania Cardinali, Roberta Russo, Silvia Laforgia, Nicola Faienza, Maria Felicia |
author_facet | Simonetti, Simonetta D’Amato, Gabriele Esposito, Benedetta Chiarito, Mariangela Dentico, Domenico Lorè, Tania Cardinali, Roberta Russo, Silvia Laforgia, Nicola Faienza, Maria Felicia |
author_sort | Simonetti, Simonetta |
collection | PubMed |
description | BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a single central laboratory, as well as to analyze the growth characteristics and the associated risk factors of the CH newborns diagnosed during the study period. METHODS: Data derived from the reorganization of the newborn screening program for CH in a single central laboratory that collects dried blood spot (DBS) from 27 Maternity Hospitals are analyzed over a three-year period. Birth weight and length, daily dose of L-T4 at specific key points (3, 6, 12 and 18 months, 2, 2.5 and 3 years) were also obtained from medical records of the CH newborns during the study period and calculated as standard deviation score (SDS). RESULTS: The screening program diagnosed 90 newborns with confirmed CH (incidence 1:990; recall rate: 3.6%). In detail, 75.6% newborns had an eutopic thyroid, and 24.4% had thyroid dysgenesis; 33 out of the 90 newborns (36.6%) had one or more risk factors. Among these, the multiple pregnancies are the most important because they tripled the risk of CH. At diagnosis, TSH levels were different between patients with dysgenesis and those with an eutopic thyroid (p = 0.005). Treatment was started at a mean of 18.5 ± 12.8 days of life. The mean starting dose of levothyroxine (L-T4) was 11.38 ± 2.46 μg/kg/day. CONCLUSIONS: The results of these study show an increase of CH cases in newborns with an eutopic thyroid compared to the traditional classification. The centralization of the screening program allows a closer cooperation between laboratory and clinical centers and facilitates the implementation of appropriate diagnostic evaluations and timely initiation of treatment, with positive effects on the management of the condition. |
format | Online Article Text |
id | pubmed-9335966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93359662022-07-30 Congenital hypothyroidism after newborn screening program reorganization in the Apulia region Simonetti, Simonetta D’Amato, Gabriele Esposito, Benedetta Chiarito, Mariangela Dentico, Domenico Lorè, Tania Cardinali, Roberta Russo, Silvia Laforgia, Nicola Faienza, Maria Felicia Ital J Pediatr Research BACKGROUND: Congenital hypothyroidism (CH) is the most frequent congenital endocrine disorder. The purpose of the present study was to evaluate the incidence and etiological classification of CH in Apulia in a three-year period according to the reorganization of the regional screening program in a single central laboratory, as well as to analyze the growth characteristics and the associated risk factors of the CH newborns diagnosed during the study period. METHODS: Data derived from the reorganization of the newborn screening program for CH in a single central laboratory that collects dried blood spot (DBS) from 27 Maternity Hospitals are analyzed over a three-year period. Birth weight and length, daily dose of L-T4 at specific key points (3, 6, 12 and 18 months, 2, 2.5 and 3 years) were also obtained from medical records of the CH newborns during the study period and calculated as standard deviation score (SDS). RESULTS: The screening program diagnosed 90 newborns with confirmed CH (incidence 1:990; recall rate: 3.6%). In detail, 75.6% newborns had an eutopic thyroid, and 24.4% had thyroid dysgenesis; 33 out of the 90 newborns (36.6%) had one or more risk factors. Among these, the multiple pregnancies are the most important because they tripled the risk of CH. At diagnosis, TSH levels were different between patients with dysgenesis and those with an eutopic thyroid (p = 0.005). Treatment was started at a mean of 18.5 ± 12.8 days of life. The mean starting dose of levothyroxine (L-T4) was 11.38 ± 2.46 μg/kg/day. CONCLUSIONS: The results of these study show an increase of CH cases in newborns with an eutopic thyroid compared to the traditional classification. The centralization of the screening program allows a closer cooperation between laboratory and clinical centers and facilitates the implementation of appropriate diagnostic evaluations and timely initiation of treatment, with positive effects on the management of the condition. BioMed Central 2022-07-29 /pmc/articles/PMC9335966/ /pubmed/35906638 http://dx.doi.org/10.1186/s13052-022-01328-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Simonetti, Simonetta D’Amato, Gabriele Esposito, Benedetta Chiarito, Mariangela Dentico, Domenico Lorè, Tania Cardinali, Roberta Russo, Silvia Laforgia, Nicola Faienza, Maria Felicia Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title | Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title_full | Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title_fullStr | Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title_full_unstemmed | Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title_short | Congenital hypothyroidism after newborn screening program reorganization in the Apulia region |
title_sort | congenital hypothyroidism after newborn screening program reorganization in the apulia region |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335966/ https://www.ncbi.nlm.nih.gov/pubmed/35906638 http://dx.doi.org/10.1186/s13052-022-01328-0 |
work_keys_str_mv | AT simonettisimonetta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT damatogabriele congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT espositobenedetta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT chiaritomariangela congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT denticodomenico congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT loretania congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT cardinaliroberta congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT russosilvia congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT laforgianicola congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion AT faienzamariafelicia congenitalhypothyroidismafternewbornscreeningprogramreorganizationintheapuliaregion |